Categories Technology

PagerDuty stock opens up more than 50% from its IPO price on debut day

Shares of San Francisco-based tech firm PagerDuty (NYSE: PD) opened at $36.75, up 53% from its IPO price of $24 on its first day of trading on NYSE. PagerDuty increased its IPO price range from $19 to $21 to a range of $21 to $23 on Tuesday. Market watchers expected the $1.8 billion valued company to open up between $30 and $32.

Yesterday, PagerDuty announced that its 9.07 million shares of common stock will be priced at $24 per share. Morgan Stanley and J.P. Morgan Securities acted as lead book-running managers for the offering. RBC Capital Markets and Allen & Company acted as joint bookrunners.

PagerDuty PD stock IPO - Finanacials

According to Crunchbase, the 10-year old software maker had raised over $170 million in six rounds of funding before going public. This includes investments from Andreessen Horowitz, Bessemer Venture Partners and Accel Partners.

Also read: Lyft and six other companies went public in March

For the fiscal year 2019 ended on January 31, 2019, net loss was $40.7 million compared to a net loss of $38.1 million in the previous year. Revenue grew 48% year-over-year to $117.8 million.

PagerDuty’s global customer base at the end of fiscal year 2019 grew to 11,212 from 9,793 at January 31, 2018. One-third of this customer base includes Fortune 500 companies. No single customer represented 5% or more of the company’s revenue for the fiscal year ended January 31, 2019.

PagerDuty’s SaaS-based solution provides insights to customers about their business performance, evaluates their applications and automate them, and increase their productivity.

Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips

 

 

Most Popular

Cost reduction has become a priority for FedEx (FDX) after a challenging quarter

Shares of FedEx Corporation (NYSE: FDX) were up 1% on Tuesday. The stock has dropped 44% year-to-date and 34% over the past 12 months. The company delivered mixed results for

Prime Medicine is the next big biotech to pursue IPO. Here’s all you need to know

After a soft start to the year, the IPO market has witnessed muted activity so far though a few big companies entered the stock market. On the heels of AIG

Stock Watch: Is Darden Restaurants a good buy after earnings?

After a prolonged slowdown, the restaurant industry is returning to normal patterns but macroeconomic uncertainties and high inflation are currently playing spoilsport for it. While the pandemic-related slump forced many

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top